Figure 1 The trajectory of cognitive ageing

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Case Study: Chaplain Pat

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Life expectancy at birth in all countries included

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 The US Centers for Disease Control and

Figure 4 Time course of the development of physiological changes

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Overview of risk factors for Parkinson disease dementia

Figure 1 General framework of brain–computer interface (BCI) systems

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Proportion of patients for whom NEDA

Figure 5 Number of AHSCT procedures for

Figure 1 Diagnostic tiers of Parkinson disease as single disease

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Characterization of anatomical damage

Figure 1 Allele frequency and effect size for ALS-associated genes

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Hypothetical mechanisms of smoking-associated

Figure 2 Poststroke plasticity and recovery

Figure 2 Precision medicine based on a network approach

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Principles of therapeutic ultrasound

Figure 1 Cardiovascular risk and disease across the life-course

Figure 1 Clinical correlates of neurodegeneration in MS

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Genetic pleiotropy in ALS

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Evolution of multiple sclerosis

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Anatomical location of cerebral microbleeds (CMBs)

Figure 3 Challenges for big data applications in cardiovascular care

Figure 1 Proportional motor recovery in the upper limb

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 2 Age-specific prevalence of common comorbidities

Figure 6 Combining population-wide and high-risk strategies

Figure 1 Ischaemic stroke prevalence and mortality

Figure 3 Potential interplay between physiological

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 The VEGF family of growth factors

Nat. Rev. Nephrol. doi: /nrneph

Figure 1 Tau PET images in patients with Alzheimer disease

Figure 2 Cellular pathways implicated in CIPN

Figure 1 Hypothetical conceptual frameworks for CRPS

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Timing of the effects of deep brain stimulation

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 A large number of genes are potentially associated with CIPN

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Neurol. doi: /nrneurol

Association of total disease burden with age, m

Figure 2 Functionally significant genes

Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Craniospinal irradiation proton therapy for medulloblastoma

Figure 2 Hypothetical model of temporal brain changes

Figure 2 Network connections of the hypothalamus

Maria R. Costanzo et al. JCHF 2016;4:

Presentation transcript:

Figure 1 The trajectory of cognitive ageing Figure 1 | The trajectory of cognitive ageing. Graphic display depicting the hypothetical trajectories of 'normal' cognitive ageing (red) that reflects presumed 'normal' age-related increases in cerebral pathologies (dotted line), the effects of reducing the contribution of these factors to cognitive ageing (purple), the effects of increasing resilience (orange), providing optimal supportive care (blue), and optimizing ability (green).The dotted line indicates the increased risk of brain injury and the dashed line indicates the reduction in risk of brain injury that can potentially be achieved, as suggested by Gorelick et al.2. DeCarli, C. (2017) ‘Brain health’: what is it, what can we do about it and when should we start? Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.169